Serine protease hepsin (191-199)

Serine protease hepsin (191-199) is a synthetic peptide fragment derived from the C-terminal region of the human hepsin enzyme, a type II transmembrane serine protease. This peptide encompasses a sequence associated with the substrate-binding or regulatory domains of hepsin, a protease implicated in a variety of physiological and pathological processes, including extracellular matrix remodeling, cell signaling, and tissue homeostasis. As a chemically defined peptide, it provides researchers with a valuable tool for dissecting the structural and functional roles of hepsin's active site and its interaction with substrates or inhibitors. Its defined sequence and origin make it particularly relevant for studies aiming to elucidate the molecular mechanisms underlying serine protease activity and regulation.

Enzyme mechanism studies: Researchers utilize the hepsin (191-199) peptide to investigate the substrate specificity and catalytic mechanisms of serine proteases, particularly those within the hepsin family. By serving as a representative substrate or competitive inhibitor in biochemical assays, this peptide enables detailed kinetic analyses and mapping of enzyme-substrate interactions. Such studies contribute to a deeper understanding of the determinants governing proteolytic activity, substrate recognition, and the influence of sequence context on enzymatic function.

Protease inhibitor screening: The defined sequence of this peptide fragment makes it a suitable model substrate for high-throughput screening platforms designed to identify and characterize novel inhibitors of hepsin and related serine proteases. By monitoring the cleavage or binding of the peptide in the presence of candidate compounds, researchers can efficiently assess inhibitor potency, specificity, and mechanism of action. This application is critical for the development of chemical probes and for advancing the field of protease-targeted drug discovery research.

Antibody generation and epitope mapping: The hepsin (191-199) peptide serves as an immunogen or epitope standard in the generation and validation of antibodies targeting specific regions of the hepsin protein. Its use in immunization protocols or affinity purification workflows allows for the production of highly specific antibodies, which are instrumental for immunodetection, localization, and quantification of hepsin in various biological samples. Additionally, the peptide facilitates fine mapping of antibody binding sites, thereby supporting the development of reliable immunoassays.

Protein-protein interaction studies: As a representative segment of the hepsin molecule, this peptide is employed in binding assays and structural studies to probe interactions with natural substrates, regulatory proteins, or synthetic ligands. Its application in surface plasmon resonance, isothermal titration calorimetry, or NMR-based assays enables the characterization of binding affinities and interaction interfaces. These insights are essential for unraveling the regulatory networks involving serine proteases and for identifying potential modulators of their activity.

Peptide-based assay development: The hepsin (191-199) sequence is frequently incorporated into the design of custom biochemical assays aimed at monitoring protease activity, specificity, or inhibition under defined conditions. Its use as a substrate or reference standard supports the optimization and validation of fluorometric, colorimetric, or mass spectrometric methods. These assays are indispensable for basic research, preclinical studies, and the evaluation of protease function in complex biological systems.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes